The 3rd Rx-to-OTC Switch Summit will be held December 1-2, 2016 in Philadelphia, PA. This event focuses on all aspects of the switch from prescription drug to over the counter product, including safe use, packaging, comprehendible label writing, marketing techniques, successful case studies and federal initiatives.
Over the course of two days, those in attendance will hear from an expert speaking faculty and network with seasoned professionals working toward the next generation of OTC drug availability. Speakers will relay information through detailed presentations, intensive case studies and collaborative panel discussions, maximizing the learning experience. In addition, designated lunches and networking breaks will enhance the knowledge exchange and foster future business partnerships.
Top Five Reasons to Attend
Assess the current switch market and profile future potential switches
Hear from an expert speaking faculty representing pharmaceutical and biotechnology organizations on pressing issues such as safe use, label writing and packaging for OTC drugs
Learn examples of successful and failed switches and what caused their outcomes
Discuss the latest regulatory challenges and initiatives including NSURE
Network with industry professionals to exchange best practices for ensuring profitability following an Rx-to-OTC switch